New Partnership Adds Award-winning Clinical Research Leader, Dr. Donald Hurley, to Wake Research’s National Network
M3 Wake Research, a leading fully integrated network of clinical research sites and one of North America’s largest providers of Phase I-IV clinical trials, is expanding operations into Charleston, SC with the opening of a clinical research practice. Operating as Charleston Clinical Trials, LLC, the new center is led by Donald Hurley, DO, and located at 2270 Ashley Crossing Drive in Charleston.
Dr. Hurley will serve as Principal Investigator. He brings more than 35 years of clinical experience to Charleston Clinical Trials, including 18 years in clinical research as a principal and sub-investigator in more than 40 therapeutic areas, with Medical Research South, LLC.
“I am excited to join the M3 Wake Research network and anticipate the continued growth of our Phase 2-4 trial base here in Charleston,” said Dr. Hurley. “This is a diverse, active market in a growing area, and we look forward to providing access to more investigative therapies to the community here.”
Dr. Hurley has practiced in South Carolina for most of his career after some stints working in Georgia, Virginia, and overseas deployments in the US Navy. He has obtained numerous professional awards including six years of recognition among “America’s Top Family Doctors,” between 2002-2021, two Navy Commendation Medals, two Navy Achievement medals, and a commendation letter for his work with the White House Medical Unit, among many other achievements throughout his career.
Dr. Hurley is supported by an experienced clinical research team including a Certified Clinical Research Coordinator who is managing the site operations of Charleston Clinical Trials.
The Charleston team will provide clinical research services in a variety of therapeutic areas including vaccines, gastroenterology, cardiovascular disease (hypertension, etc), diabetes, urology (UTIs, etc), and more.
Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!